Hong Kong
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
21.21%
|
Dec. 31, 2023 | USD 1.45 | -2.13% |
|
Hong Kong |
|
2 |
19.02%
|
Dec. 31, 2023 | USD 0.40 | NA |
|
Hong Kong |
|
3 |
15.47%
|
Dec. 31, 2023 | USD 0.91 | NA |
|
Hong Kong |
|
4 |
13.80%
|
Dec. 31, 2023 | USD 2.63 | -1.97% |
|
Hong Kong |
|
5 |
12.23%
|
Dec. 31, 2023 | USD 0.41 | -3.06% |
|
Hong Kong |
|
6 |
10.01%
|
Dec. 31, 2023 | USD 0.19 | -0.06% |
|
Hong Kong |
|
7 |
6.07%
|
Dec. 31, 2023 | USD 0.24 | -0.06% |
|
Hong Kong |
|
8 |
3.16%
|
Dec. 31, 2023 | USD 0.21 | -2.41% |
|
Hong Kong |
|
9 |
0.82%
|
Dec. 31, 2023 | USD 0.16 | 4.01% |
|
Hong Kong |
|
10 |
-24.93%
|
Dec. 31, 2023 | USD 17.32 | NA |
|
Hong Kong |
|
11 |
-30.40%
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
12 |
-195.77%
|
Dec. 31, 2023 | USD 0.36 | -3.86% |
|
Hong Kong |
The Biotechnology company in Hong Kong with the highest Return on Equity (ROE) is The United Laboratories International Holdings Limited (HKSE: 3933.HK) at 21.21%.
The Biotechnology company in Hong Kong with the lowest Return on Equity (ROE) is Sirnaomics Ltd. (HKSE: 2257.HK) at -195.77%.
The top 10 Biotechnology companies in Hong Kong by Return on Equity (ROE) are The United Laboratories International Holdings Limited, SSY Group Limited, China Medical System Holdings Limited, HUTCHMED (China) Limited, OrbusNeich Medical Group Holdings Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, China Traditional Chinese Medicine Holdings Co. Limited, Frontage Holdings Corporation, Lee's Pharmaceutical Holdings Limited and BeiGene, Ltd..
The bottom 10 Biotechnology companies in Hong Kong by Return on Equity (ROE) are Sirnaomics Ltd., Prenetics Global Limited, BeiGene, Ltd., Lee's Pharmaceutical Holdings Limited, Frontage Holdings Corporation, China Traditional Chinese Medicine Holdings Co. Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, OrbusNeich Medical Group Holdings Limited, HUTCHMED (China) Limited and China Medical System Holdings Limited.